Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlobeImmune Inc (NASDAQ:GBIM)

1.99
Delayed Data
As of Feb 09
 -0.18 / -8.29%
Today’s Change
1.43
Today|||52-Week Range
10.95
-48.58%
Year-to-Date
No recent news for GlobeImmune Inc.

Today’s Trading

Previous close2.17
Today’s open2.11
Day’s range1.98 - 2.13
Volume28,557
Average volume (3 months)72,363
Market cap$12.5M
Dividend yield--
Data as of 02/09/2016

Growth & Valuation

Earnings growth (last year)-572.52%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-73.50%
P/E ratioNM
Price/Sales3.71
Price/Book2.23

Competitors

 Today’s
change
Today’s
% change
GBSNGreat Basin Scientif...-0.01-4.45%
APPYVenaxis Inc-0.01-5.60%
APHBAmpliPhi Biosciences...-0.26-7.62%
GALTUGalectin Therapeutic...0.000.00%
Data as of 02/09/2016

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$6.0M
Annual profit (last year)-$16.3M
Net profit margin-272.54%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Timothy C. Rodell
Secretary, Treasurer &
Vice President-Finance
C. Jeffrey Dekker
Corporate headquarters
Louisville, Colorado

Forecasts

Partner Offers